Michael Hagan
About Michael J. Hagan
Michael J. Hagan (Age: 62) is a Class A Director at FSK, serving since 2011, and the Board’s Lead Independent Director; his current term expires in 2026 . He is Managing Partner and co‑founder of Hawk Capital Partners (since December 2014), and previously held CEO/President roles at LifeShield and NutriSystem, with early career leadership at Verticalnet; he holds a B.S. in Accounting from Saint Joseph’s University and is an inactive CPA . He also serves on the boards of trustees of K‑FIT and K‑FITS and previously served on the FSKR board until the merger with FSK .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Hawk Capital Partners | Co‑founder; Managing Partner | Dec 2014–present | Private equity leadership |
| LifeShield, Inc. | Chairman, President & CEO | Dec 2009–May 2013 | Led sale to DirecTV division in 2013 |
| LifeShield, Inc. | President | Jun 2013–May 2014 | Post‑acquisition leadership |
| NutriSystem, Inc. | Chairman; CEO; President | 2002–Nov 2008 (CEO to May 2008; President Jul 2006–Sep 2007) | Board chair, operational leadership |
| Verticalnet Inc. | Co‑founder; multiple executive roles | 1995–2005 (Chair), 2000–2002 (COO), 2001–2002 (CEO), SVP earlier | B2B technology operator |
| Actua Corporation (ICG Group) | Director | Jun 2007–Feb 2018 | Governance oversight |
| American Financial Realty Trust | Trustee | 2003–Jun 2007 | Board service |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| KKR FS Income Trust (K‑FIT) | Trustee | Current | Fund complex oversight |
| KKR FS Income Trust Select (K‑FITS) | Trustee | Current | Fund complex oversight |
| NutriSystem, Inc. | Director; prior Chairman | Feb 2021–present; 2012–2019 Chair; 2002–2008 Director | Longstanding consumer sector experience |
| FSKR (FS KKR Capital Corp. II) | Director | Until merger in Jun 2021 | Board service pre‑merger |
Board Governance
- Lead Independent Director responsibilities: agenda setting with Chair/CEO, chairs executive sessions of independent directors, facilitates Board‑management communications, and consults on governance/Board performance .
- Committees and membership:
- Nominating & Corporate Governance Committee: members Harrow (Chair), Hagan, Hopkins; held 2 meetings in 2024 .
- Audit Committee: Ford (Chair), Kropp, Imasogie; 8 meetings in 2024 .
- Valuation Committee: Adams, Sandler, Kropp (Chair), Hopkins, Goldstein, Imasogie; 4 meetings in 2024 .
- Compensation Committee: Ford (Chair), Kropp, Imasogie; 1 meeting in 2024 .
- Independence and attendance: FSK’s majority‑independent Board (as required for BDCs); each director attended at least 75% of Board and committee meetings in 2024; Board met 9 times; no directors attended the 2024 annual stockholder meeting .
- Board structure: CEO (Forman) also serves as Chair; Board concluded structure appropriate given BDC regulation and NYSE listing .
Fixed Compensation
- Director cash fee schedule (effective August 1, 2024; paid quarterly; allocated across Fund Complex):
- Annual Board Retainer: $200,000; Lead Independent Director Retainer: $30,000; Committee Chair Retainers: Audit $35,000, Valuation $35,000, Nominating & Corporate Governance $15,000; Audit Committee Member Retainer: $5,000 (not paid to chair); Valuation Committee Member Retainer: $10,000 (not paid to chair). Directors are reimbursed for reasonable meeting expenses; no retirement benefits .
- Hagan’s 2024 compensation:
- Total Fees Earned/Paid in Cash by FSK: $222,384; Total Compensation from Fund Complex: $232,500 .
| Item | Amount |
|---|---|
| Annual Board Retainer | $200,000 |
| Lead Independent Director Retainer | $30,000 |
| Audit Committee Chair Retainer | $35,000 |
| Valuation Committee Chair Retainer | $35,000 |
| Nominating & Corporate Governance Chair Retainer | $15,000 |
| Audit Committee Member Retainer (non‑chair) | $5,000 |
| Valuation Committee Member Retainer (non‑chair) | $10,000 |
| Hagan – Total FSK Cash Fees (FY2024) | $222,384 |
| Hagan – Total Fund Complex Compensation (FY2024) | $232,500 |
Compensation structure changes: Prior to Aug 1, 2024, Audit/Valuation chair retainers were $25,000; increased to $35,000 thereafter, signaling higher committee leadership compensation .
Performance Compensation
- No director equity awards or options granted in FY2024; Item 402(x) shows no options/SARs granted .
- FSK’s directors are compensated via cash retainers; no disclosure of RSUs/PSUs, option awards, or performance‑tied director equity programs .
| Metric | Disclosure |
|---|---|
| RSUs/PSUs for directors | Not disclosed; no grants in FY2024 |
| Stock options for directors | None granted in FY2024 |
| Performance metrics tied to director pay | Not applicable (cash retainers) |
Other Directorships & Interlocks
| Company/Entity | Role | Tenure | Interlocks/Notes |
|---|---|---|---|
| K‑FIT; K‑FITS | Trustee | Current | Fund complex alignment with FSK |
| FSKR | Director | Until merger (Jun 2021) | Prior affiliate fund board |
| NutriSystem, Inc. | Director; prior Chairman | 2002–2008 Director; 2012–2019 Chair; since Feb 2021 Director | Consumer sector public company experience |
| Verticalnet Inc. | Chairman/CEO/COO/SVP | 1995–2005 (Chair); 2000–2002 (COO); 2001–2002 (CEO) | Tech/operator background |
| Actua Corporation (ICG Group) | Director | Jun 2007–Feb 2018 | Governance expertise |
| American Financial Realty Trust | Trustee | 2003–Jun 2007 | Real estate sector board service |
Expertise & Qualifications
- Financial/accounting expertise (inactive CPA), corporate finance, private equity, and controls; entrepreneurial and senior executive experience in public/private companies .
- Lead Independent Director governance responsibilities reflect engagement in agendas, executive sessions, and communications .
Equity Ownership
- Beneficial ownership as of March 31, 2025:
- Michael J. Hagan: 33,302 shares; reported dollar range of beneficial ownership “Over $100,000”; <1% of shares outstanding per proxy .
- Insider trading/hedging/pledging policies:
- Prohibits hedging/monetization, short sales, derivatives, margin accounts, and pledging of FSK securities without advance approval; trades only in window periods with pre‑clearance; Section 16 filings reported as timely for FY2024 .
| Item | Value |
|---|---|
| Shares beneficially owned (Hagan) | 33,302 |
| Ownership % | <1% (per proxy asterisk) |
| Dollar range of ownership | Over $100,000 |
| Hedging/Pledging | Prohibited absent approval; pre‑clearance required |
| Section 16 compliance (FY2024) | All filings timely |
Governance Assessment
-
Strengths
- Lead Independent Director role enhances independent oversight (agenda control, executive sessions, comms) .
- Active membership on Nominating & Corporate Governance Committee; independence affirmed; committee met during FY2024 .
- Meaningful share ownership with strict anti‑hedging/anti‑pledging policy supports alignment .
- Robust committee cadence (Audit 8; Valuation 4; Nominating 2; Comp 1) indicates engaged governance processes .
-
Potential Risks/RED FLAGS
- External management structure (FS/KKR Advisor) can create inherent conflicts; related‑party transactions reviewed by Audit Committee and governed by policies, but continuous vigilance needed .
- No attendance by any directors at the 2024 annual stockholder meeting—optics negative for investor engagement despite meeting attendance ≥75% .
- Multiple fund complex roles (K‑FIT/K‑FITS trusteeship) create interlocks across affiliated vehicles; important to ensure independent judgment in FSK oversight .
-
Compensation Structure Signals
- Increase in committee chair fees (Audit/Valuation) from $25,000 to $35,000 suggests heightened expectations for oversight and time commitment; cash‑only structure avoids equity misalignment risk but limits direct pay‑for‑performance linkage .
- Lead Independent Director retainer ($30,000) formalizes added governance responsibilities .
-
Independence & Effectiveness
- Hagan meets independence criteria, maintains active governance responsibilities, and brings financial/accounting depth; attendance threshold met and executive session leadership is positive for Board effectiveness .
No specific related‑party transactions involving Hagan are disclosed; the company’s Code and Audit Committee policies require review/approval of any such transactions and adherence to arm’s‑length terms .